Utilizing systematic reviews and meta-analyses effectively to evaluate brain tumor biomarkers

Biomark Med. 2020 Jul;14(10):817-820. doi: 10.2217/bmm-2020-0209. Epub 2020 Aug 17.

Authors

Victor M Lu^{1

2}, Ashish H Shah¹, Daniel G Eichberg¹, Evan M Luther¹, Sumedh S Shah¹, Ricardo J Komotar¹, Michael E Ivan¹

Affiliations

¹ Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
² Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA.

PMID: 32799644
DOI: 10.2217/bmm-2020-0209

No abstract available

Keywords: IDH; biomarker; brain tumor; glioblastoma; meta-analyses; methodology; systematic review.

Publication types

Editorial

MeSH terms

Biomarkers, Tumor* / blood
Biomarkers, Tumor* / metabolism
Brain Neoplasms* / diagnosis
Brain Neoplasms* / metabolism
Humans
Meta-Analysis as Topic*

Substances

Biomarkers, Tumor